Psoriasis patient preferences for topical drugs: a systematic review
Background Topical drugs are recommended first-line treatment for mild-to-moderate psoriasis. However, patient preferences for the topical drugs differ, since a wide variety of topical drugs and topical drug formulations are available. Objectives The aim of this study was to investigate psoriasis pa...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-07-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2019.1675855 |
_version_ | 1797683650119073792 |
---|---|
author | Mathias Tiedemann Svendsen Steven R. Feldman Sylvia Naiga Tiedemann Anne Sofie Stochholm Sørensen Cecilie Marie Ringgaard Rivas Klaus Ejner Andersen |
author_facet | Mathias Tiedemann Svendsen Steven R. Feldman Sylvia Naiga Tiedemann Anne Sofie Stochholm Sørensen Cecilie Marie Ringgaard Rivas Klaus Ejner Andersen |
author_sort | Mathias Tiedemann Svendsen |
collection | DOAJ |
description | Background Topical drugs are recommended first-line treatment for mild-to-moderate psoriasis. However, patient preferences for the topical drugs differ, since a wide variety of topical drugs and topical drug formulations are available. Objectives The aim of this study was to investigate psoriasis patient preferences for topical drugs. Methods A systematic literature search was performed for English-language articles in Embase, Medline, PsycINFO, Cinahl, Scopus, and the Cochrane Library. Results Four surveys, six randomized controlled trials, and two prospective studies of mainly good quality were included. Seven of the studies investigated patient preferences for topical drug formulations, while five studies investigated their preferences for different topical drugs. Overall, patients preferred drugs that are easy to apply, less messy, and have a pleasant scent. Conclusion Psoriasis patient preferences for topical drugs differ. There is no one topical drug or topical drug formulation that suits everyone, which shows the importance of individualized prescriptions for topical drugs that are based on shared decision-making between the prescriber and patient. |
first_indexed | 2024-03-12T00:17:37Z |
format | Article |
id | doaj.art-03f52075fb8e4f24981904394bbd7c30 |
institution | Directory Open Access Journal |
issn | 0954-6634 1471-1753 |
language | English |
last_indexed | 2024-03-12T00:17:37Z |
publishDate | 2021-07-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Journal of Dermatological Treatment |
spelling | doaj.art-03f52075fb8e4f24981904394bbd7c302023-09-15T14:23:03ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532021-07-0132547848310.1080/09546634.2019.16758551675855Psoriasis patient preferences for topical drugs: a systematic reviewMathias Tiedemann Svendsen0Steven R. Feldman1Sylvia Naiga Tiedemann2Anne Sofie Stochholm Sørensen3Cecilie Marie Ringgaard Rivas4Klaus Ejner Andersen5Research Unit of the Dermato-Venerology and Allergy Center, University of Southern DenmarkResearch Unit of the Dermato-Venerology and Allergy Center, University of Southern DenmarkFaculty of Medicine and Health Sciences, University of CopenhagenDepartment of Nursing in Copenhagen, Metropol University CollegeDepartment of Nursing in Copenhagen, Metropol University CollegeResearch Unit of the Dermato-Venerology and Allergy Center, University of Southern DenmarkBackground Topical drugs are recommended first-line treatment for mild-to-moderate psoriasis. However, patient preferences for the topical drugs differ, since a wide variety of topical drugs and topical drug formulations are available. Objectives The aim of this study was to investigate psoriasis patient preferences for topical drugs. Methods A systematic literature search was performed for English-language articles in Embase, Medline, PsycINFO, Cinahl, Scopus, and the Cochrane Library. Results Four surveys, six randomized controlled trials, and two prospective studies of mainly good quality were included. Seven of the studies investigated patient preferences for topical drug formulations, while five studies investigated their preferences for different topical drugs. Overall, patients preferred drugs that are easy to apply, less messy, and have a pleasant scent. Conclusion Psoriasis patient preferences for topical drugs differ. There is no one topical drug or topical drug formulation that suits everyone, which shows the importance of individualized prescriptions for topical drugs that are based on shared decision-making between the prescriber and patient.http://dx.doi.org/10.1080/09546634.2019.1675855patient preferencespsoriasistopical drugs |
spellingShingle | Mathias Tiedemann Svendsen Steven R. Feldman Sylvia Naiga Tiedemann Anne Sofie Stochholm Sørensen Cecilie Marie Ringgaard Rivas Klaus Ejner Andersen Psoriasis patient preferences for topical drugs: a systematic review Journal of Dermatological Treatment patient preferences psoriasis topical drugs |
title | Psoriasis patient preferences for topical drugs: a systematic review |
title_full | Psoriasis patient preferences for topical drugs: a systematic review |
title_fullStr | Psoriasis patient preferences for topical drugs: a systematic review |
title_full_unstemmed | Psoriasis patient preferences for topical drugs: a systematic review |
title_short | Psoriasis patient preferences for topical drugs: a systematic review |
title_sort | psoriasis patient preferences for topical drugs a systematic review |
topic | patient preferences psoriasis topical drugs |
url | http://dx.doi.org/10.1080/09546634.2019.1675855 |
work_keys_str_mv | AT mathiastiedemannsvendsen psoriasispatientpreferencesfortopicaldrugsasystematicreview AT stevenrfeldman psoriasispatientpreferencesfortopicaldrugsasystematicreview AT sylvianaigatiedemann psoriasispatientpreferencesfortopicaldrugsasystematicreview AT annesofiestochholmsørensen psoriasispatientpreferencesfortopicaldrugsasystematicreview AT ceciliemarieringgaardrivas psoriasispatientpreferencesfortopicaldrugsasystematicreview AT klausejnerandersen psoriasispatientpreferencesfortopicaldrugsasystematicreview |